These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7855692)

  • 41. [Relationship between various erythrocyte antigens and hematologic disorders].
    Arevalo C; Gajardo M; León A; Espinoza E; Marín F
    Rev Med Chil; 1989 Nov; 117(11):1221-6. PubMed ID: 2519795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD; Liang PS; Ulz L
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Our first experience of transfusion support in allogenic bone marrow transplantations.
    Fregatova L; Volkova O; Platonova G; Afanasiev B
    Beitr Infusionsther Transfusionsmed; 1994; 32():445-7. PubMed ID: 9422124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization?
    Yazer MH; Triulzi DJ; Shaz B; Kraus T; Zimring JC
    Transfusion; 2009 Jun; 49(6):1070-5. PubMed ID: 19309468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood transfusion with autologous and leukocyte-depleted or standard allogeneic red blood cells and the immune response to open heart surgery.
    Perttilä JT; Salo MS; Jalonen JR; Kuttila KT; Viinamäki O; Pulkki KJ
    Anesth Analg; 1994 Oct; 79(4):654-60. PubMed ID: 7943771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Searching for genetic markers--in the fields of forensic medicine and human genetics].
    Ikemoto S
    Nihon Hoigaku Zasshi; 1995 Dec; 49(6):419-31. PubMed ID: 8583686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of the blood group I, i, H, and A1 antigens on erythrocyte membranes studied by immunofluorescence.
    Rochant H; Henri A; Tonthat H; Titeux M; Feuilhade F
    J Clin Lab Immunol; 1980 Jul; 4(1):35-40. PubMed ID: 7007649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leukoreduction before red blood cell transfusion has no impact on mortality in trauma patients.
    Phelan HA; Sperry JL; Friese RS
    J Surg Res; 2007 Mar; 138(1):32-6. PubMed ID: 17161430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs.
    Julmy F; Ammann RA; Taleghani BM; Fontana S; Hirt A; Leibundgut K
    Transfusion; 2009 Jan; 49(1):21-33. PubMed ID: 18774963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymer-mediated immunocamouflage of red blood cells: effects of polymer size on antigenic and immunogenic recognition of allogeneic donor blood cells.
    Wang D; Kyluik DL; Murad KL; Toyofuku WM; Scott MD
    Sci China Life Sci; 2011 Jul; 54(7):589-98. PubMed ID: 21701803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. rs660 polymorphism in Ro52 (SSA1; TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease.
    Tatari-Calderone Z; Minniti CP; Kratovil T; Stojakovic M; Vollmer A; Barjaktarevic I; Zhang E; Hoang A; Luban NL; Vukmanovic S
    Mol Immunol; 2009 Nov; 47(1):64-70. PubMed ID: 19201475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Failure of normal red blood cells to become Tn-activated when transfused into a patient with Tn-polyagglutination.
    Reid ME; Ellisor SS; Swanson J; Edwards G; Stanik F
    Am J Med Technol; 1980 Sep; 46(9):670-2. PubMed ID: 7416196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Specificity and clinical features of erythrocytic allo-antibodies in hospitalized patients].
    Wu BT; Yao DG; Rong RM
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1691-3. PubMed ID: 21914318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes.
    Michail-Merianou V; Pamphili-Panousopoulou L; Piperi-Lowes L; Pelegrinis E; Karaklis A
    Vox Sang; 1987; 52(1-2):95-8. PubMed ID: 3300026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993.
    Hoeltge GA; Domen RE; Rybicki LA; Schaffer PA
    Arch Pathol Lab Med; 1995 Jan; 119(1):42-5. PubMed ID: 7802552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neonatal transfusion review.
    Sloan SR
    Paediatr Anaesth; 2011 Jan; 21(1):25-30. PubMed ID: 21155924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of haemotherapy in thalassaemias (20 years of Indian experience).
    Jolly JG; Agnihotri SK; Choudhury N; Gupta D
    J Indian Med Assoc; 1992 Jan; 90(1):7-9. PubMed ID: 1593146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A review of serologic problems caused by polyagglutinable red cells.
    Wilson J
    Am J Med Technol; 1977 Feb; 43(2):147-55. PubMed ID: 402072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acquired red blood cell alloantibodies in transfused patients of 80 years or over: a 2008-2013 national haemovigilance survey.
    Moncharmont P; Barday G; Py JY; Meyer F;
    Blood Transfus; 2017 May; 15(3):254-258. PubMed ID: 27416567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of erythrocyte alloimmunization in polytransfused patients.
    Cruz Rde O; Mota MA; Conti FM; Pereira RA; Kutner JM; Aravechia MG; Castilho L
    Einstein (Sao Paulo); 2011 Jun; 9(2):173-8. PubMed ID: 26760811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.